Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 7,600 shares, a decline of 32.7% from the August 15th total of 11,300 shares. Based on an average trading volume of 104,100 shares, the short-interest ratio is presently 0.1 days.

Ono Pharmaceutical Stock Performance

OTCMKTS OPHLY traded up $0.02 on Monday, hitting $4.45. 211,624 shares of the company’s stock traded hands, compared to its average volume of 131,307. Ono Pharmaceutical has a 1-year low of $4.32 and a 1-year high of $6.69. The firm’s 50-day moving average price is $4.77 and its two-hundred day moving average price is $4.90.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.